Inscription Capital LLC Cuts Stock Position in CME Group Inc. (NASDAQ:CME)

Inscription Capital LLC trimmed its position in shares of CME Group Inc. (NASDAQ:CME) by 4.8% in the 3rd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,073 shares of the financial services provider’s stock after selling 104 shares during the quarter. Inscription Capital LLC’s holdings in CME Group were worth $457,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Oak Harvest Investment Services grew its stake in CME Group by 66.5% during the 1st quarter. Oak Harvest Investment Services now owns 45,093 shares of the financial services provider’s stock valued at $9,708,000 after purchasing an additional 18,017 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its stake in CME Group by 21.2% during the 2nd quarter. Wealth Enhancement Advisory Services LLC now owns 48,205 shares of the financial services provider’s stock valued at $9,477,000 after acquiring an additional 8,443 shares during the period. Duality Advisers LP acquired a new stake in CME Group during the 1st quarter valued at approximately $1,455,000. SG Americas Securities LLC boosted its holdings in shares of CME Group by 312.2% in the 1st quarter. SG Americas Securities LLC now owns 56,768 shares of the financial services provider’s stock valued at $12,222,000 after acquiring an additional 42,996 shares during the last quarter. Finally, Cetera Investment Advisers increased its stake in shares of CME Group by 429.1% in the first quarter. Cetera Investment Advisers now owns 47,521 shares of the financial services provider’s stock worth $10,231,000 after acquiring an additional 38,540 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

Insider Buying and Selling at CME Group

In other news, CFO Lynne Fitzpatrick sold 754 shares of the stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total transaction of $163,610.46. Following the sale, the chief financial officer now owns 13,261 shares of the company’s stock, valued at approximately $2,877,504.39. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. In related news, Director Bryan T. Durkin sold 7,593 shares of the business’s stock in a transaction on Friday, August 30th. The stock was sold at an average price of $214.59, for a total transaction of $1,629,381.87. Following the completion of the transaction, the director now directly owns 55,607 shares of the company’s stock, valued at $11,932,706.13. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CFO Lynne Fitzpatrick sold 754 shares of CME Group stock in a transaction dated Sunday, September 15th. The shares were sold at an average price of $216.99, for a total value of $163,610.46. Following the completion of the transaction, the chief financial officer now owns 13,261 shares of the company’s stock, valued at $2,877,504.39. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.30% of the stock is currently owned by corporate insiders.

CME Group Stock Performance

Shares of CME Group stock opened at $228.12 on Tuesday. The firm has a market cap of $82.14 billion, a PE ratio of 25.95, a price-to-earnings-growth ratio of 7.76 and a beta of 0.55. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $230.36. The business’s fifty day simple moving average is $219.32 and its 200-day simple moving average is $208.98.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The firm had revenue of $1.58 billion during the quarter, compared to analysts’ expectations of $1.59 billion. CME Group had a net margin of 56.98% and a return on equity of 12.82%. The firm’s quarterly revenue was up 18.4% on a year-over-year basis. During the same quarter last year, the company posted $2.25 EPS. Equities analysts forecast that CME Group Inc. will post 10.04 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Wednesday, September 25th. Investors of record on Monday, September 9th were issued a dividend of $1.15 per share. This represents a $4.60 dividend on an annualized basis and a yield of 2.02%. The ex-dividend date was Monday, September 9th. CME Group’s dividend payout ratio (DPR) is 52.33%.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on the stock. Citigroup upped their price target on shares of CME Group from $250.00 to $255.00 and gave the company a “buy” rating in a report on Thursday, October 24th. JPMorgan Chase & Co. raised their target price on CME Group from $187.00 to $191.00 and gave the stock an “underweight” rating in a report on Thursday, July 25th. Barclays boosted their price target on CME Group from $219.00 to $231.00 and gave the company an “equal weight” rating in a report on Thursday, October 24th. Piper Sandler raised their price objective on shares of CME Group from $240.00 to $250.00 and gave the stock an “overweight” rating in a research note on Monday. Finally, Keefe, Bruyette & Woods lifted their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company. According to MarketBeat, CME Group has an average rating of “Hold” and an average price target of $222.73.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.